| ExoGeni Corporation
|
|
|
| Origin
|
 Bretonia
|
| Alignment
|
Lawful/Corporation
|
| Profile
|
| Date of founding
|
802 A.S.
|
| Date of dissolution
|
N/A A.S.
|
| Founder(s)
|
Unknown
|
| Current leader(s)
|
CEO Tiberius Maxwell TD Patrick Russ
|
| Base of operations
|
Cambridge Research Station, Cambridge
|
During this period, I became interested in how the new techniques of cloning and sequencing DNA could influence the study of genetics and I was an early and active proponent of the Human Genome Sequencing Project. - Prof. Tiberius Maxwell
Description
ExoGeni is the leading genetical research department in Bretonia. In addition to funding the establishment of several bretonian colonies, ExoGeni has incidentally secured resource rights to worlds that may have undiscovered resources or remnants of alien technology, such as their newest colony on Planet Sprague. They are closely related to Cryer Pharmaceuticals. ExoGeni is known to be contracted by House militaries and privates alike for their bio-genetical implants. One of ExoGeni's subsidiaries is a private military contractor with a highly-trained security force capable of rescue, reconnaissance, and para-military operations. The corporation uses the force to secure and protect its assets and high profile employees.
History
The first founders of ExoGeni are still a shadow in the corporation's history, there are no documents about them, only that they assigned the control over the whole corporation to Professor Tiberius Maxwell. The Bretonia Police Authority had some relevant documents about ExoGeni, and those documents were dated to 802 A.S, two years after the Nomad War.
Even with all the possible documents related to ExoGeni, the whole deal on how the corporation was founded remains a mistery.
Job Opportunities
ExoGeni owned research and transport convoys increased their presence Sirius-wide since 802 A.S, their research convoys were seen in Omicron Theta, searching within the system's nebulas for artifacts. With some of the recent discoveries in xenoarcheology belonging entirely to them. Another important section of ExoGeni is their trading department, an independent section, not related to research operations, dealing in transportation.
ExoGeni Security Division
The ExoGeni Security Division (sometimes called the ExoGeni Security Corps) is a paramilitary organized security force, involved in the protection of the ExoGeni transport and research ships. They are currently lead by Security Chief Richard Gates.
ExoGeni Research Division
Organized as a mining group, the Research Division is outfitted with state of the art scientifical-mining equipment. They are seen around the Edge Nebula searching for artifacts, the whole division is controlled by a renown xenoarcheologist.
The main income of ExoGeni is based over the Turtle Creek Nebula, Kansas, in which Iridium abounds.
ExoGeni Transport Division
The ExoGeni Transport Division is a rather small but effective trading convoy, they often haul scientifical equipment and other materials.
Genetical Research Department
Patented Products:
Gene Therapy
Gene therapy is the insertion of genes into an individual's cells and tissues to alter the person's DNA. Gene therapy allows for the treatment of genetic disorders by replacing a defective mutant allele with a functional one using a carrier, also known as a vector, to deliver the therapeutic gene to the patient's target cells. Currently, the most common type of vectors are viruses that have been genetically altered to carry normal human DNA.
Medical Gel
Medi-gel (medical gel) is an all-purpose medicinal salve combining an anaesthetic and clotting agent used by paramedics, EMTs, and military personnel, produced by the ExoGeni (with [[Cryer Pharmaceuticals). It heals various wounds and ailments, instantly sealing injuries against infection and allowing for rapid healing by having the gel grip tight to flesh until subjected to a frequency of ultrasound. It is sealable against liquids - most notably blood - as well as contaminants and gases. Technically its properties make it illegal under genetic modification laws, but the restriction, in this case, is ignored because of the product's beneficial properties.
General Relations
Bretonia
